Media inquiries for Taconic Biosciences:
Michael Seiler, PhD
Vice President, Commercial
marketing@taconic.com
About Taconic Biosciences, Inc
Taconic Biosciences is a fully licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic provides the best animal solutions enabling customers to acquire, custom-generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, microbiome, immuno- oncology mouse models, and integrated model design and breeding services, Taconic operates service laboratories and breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world.
About Biospective, Inc
Biospective is a leading contract research organization (CRO) specializing in neuroscience research studies with extensively validated and readily available rodent models of ALS (TDP-43), Alzheimer's disease (beta-amyloid and tau), Parkinson's disease (alpha-synuclein), and multiple sclerosis (EAE and cuprizone) for preclinical research studies. They offer a wide range of preclinical services to evaluate therapeutic agents in these models, including dosing, motor & sensory function, cognition & sleep, electrophysiology, fluid & cellular biomarkers, in vivo imaging (MRI, CT, PET, SPECT), image processing, image analysis, histology, IHC, multiplex immunofluorescence, and spatial biology analysis. They are the industry leader in quantitative imaging biomarkers derived from multiple modalities, including MRI, PET, and SPECT, for clinical trials of Alzheimer’s disease & tauopathies, Parkinson’s disease & MSA, white matter diseases, and genetic & rare diseases.
